Nevertheless, this study has proven that the use of YAP1 inhibitors can effectively reverse the chemoresistance of oral cancer, providing suggestions for the current clinical treatment of oral cancer. This evidence concerns the gene YAP1 and lip and oral cavity carcinoma.